1. Add the LINE friend
2. Send your linking code
Copy your linking code and send it on the Taiwan stocks - Winvest LINE channel
Wait for LINE to confirm that linking is complete
Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF 00897
Close
14.54
▼ 0.22 (−1.49%)
Four-Light Health Check
Overall score
67/ 100
- 🚦 Return 🟢 Strong Same as yesterday
- 💰 Dividend 🔴 Weak Same as yesterday
- 📊 Technicals 🟢 Strong Same as yesterday
- 👁 Flows 🔴 Weak Yesterday 🟢 → Today 🔴 ↓ Weakened
💡 Worth noting today
- Health Health check: Flows light changed from green to red bearish New
- Technical KD death cross (K 67.9 / D 69.1) bearish New
- Health Overall health score down 13 points vs. yesterday bearish
VIP full research — unlimited tickers
Free reports today
of viewed today
This symbol is unlocked and counted toward today's quota
Reading on will use 1 of today's free views ( remaining)
Today's free views are used up; the allowance resets tomorrow
Don't want to wait until tomorrow? Upgrade to VIP and unlock this full analysis now
VIP has no ticker limit: every health-check factor, valuation river charts and full sector health rankings
Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF (00897) ETF Four-Light Health Check
Loading…
Health check data is being prepared. Please check back later.
💡 In one line: ()
ETF
Accumulating (no distribution)
Weighting：🚦 Return %｜💰 Dividend %｜📊 Technical %｜👁 Flows %
(dividend weight reallocated to return for accumulating ETFs)
Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF (00897)
Overall health score / 100
ETF four-light detail
- Return light -
- VIP
-
-
｜
- Dividend light - N/A
- VIP
-
-
｜
- Technical light -
- VIP
-
-
｜
- Flows light -
- VIP
-
-
｜
The underlying four-light factors are VIP content
VIP shows the actual value, rule and note of every factor, with no daily limit.
VIP full research — unlimited tickers
Free reports today
of viewed today
This symbol is unlocked and counted toward today's quota
Reading on will use 1 of today's free views ( remaining)
Today's free views are used up; the allowance resets tomorrow
VIP unlocks
- Unlimited access to the factors and rules behind every stock/ETF four-light health check
- P/E and P/B valuation river charts
- Full sector health rankings and relative positioning
- Post-close LINE alerts for your watchlist
Data as of: ｜This site is not a licensed securities investment consultancy. The four lights are a statistical summary of public information and do not constitute investment advice.
Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF (00897) Dividend history
This ETF currently makes no income distributions.
| Year | Ex-date | Price before ex-date | Cash dividend | Payment date | Cash yield |
|---|---|---|---|---|---|
Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF (00897) Total return
Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF (00897): Year-to-date return is 66.17%, 19.35% ahead of the TAIEX.
The 1-year return is 70.66%, 16.47% ahead of the TAIEX.
The 3-year return is 130.79%, 25.11% behind the TAIEX.
| Ticker | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|
Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF (00897) Holdings
The 10 largest holdings of Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF (00897) are, in order, MODERNA INC, GENMAB A/S, TWIST BIOSCIENCE CORP, Bayer AG, REGENERON PHARMACEUTICALS INC, Takeda Pharmaceutical Co Ltd, EXELIXIS INC, VERTEX PHARMACEUTICALS INC, MERCK & CO INC, REVOLUTION MEDICINES INC.
Together the top 10 holdings account for 50.9% of the fund.
| Ticker | Name | Weight | Shares held |
|---|---|---|---|
Updated:
Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF (00897) Fees & profile
Fees
| Securities transaction tax | 千分之一 |
|---|---|
| Management fee | 0.85% |
| Custodian fee | 0.20% |
| Brokerage fee | 同上市證券，由證券商訂定，但不得超過千分之一點四二五 |
Overview
| ETF name | Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF |
|---|---|
| ETF category | 國外成分股ETF(含連結式ETF) (TWSE) |
| Underlying index | NYSE FactSet全球基因免疫生技指數 |
| Founded | 2021/10/04 |
| Income distribution | 無 |
Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF (00897) Technical indicators
- Open 14.59
- High 14.59
- Low 14.5
- Close 14.54
- Volume 535
- Prev close 14.76
Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF (00897) today trades above the 20-day (monthly) MA and 60-day (quarterly) MA but still below the 5-day MA. MACD posted a death cross today and the histogram turned negative, KD is 68 and leans bullish, RSI is 53 with firm short-term momentum.
Signals today
- ● The price trades above the 20-day (monthly) MA and 60-day (quarterly) MA
- ● KD death cross
- ● MACD death cross — the histogram turned negative
Indicator values
| Item | Value |
|---|---|
| Close | 14.54 |
| 5-day MA | 14.65 |
| 20-day (monthly) MA | 14.41 |
| 60-day (quarterly) MA | 13.65 |
| 120-day (half-yearly) MA | 12.15 |
| 240-day (yearly) MA | 10.81 |
| K (9) | 67.86 |
| D (9) | 69.08 |
| RSI (14) | 53.41 |
| Bollinger upper band (20) | 15.12 |
| Bollinger lower band (20) | 13.71 |
| DIF (12,26) | 0.27 |
| MACD (9) | 0.29 |
| OSC histogram | -0.02 |
| Volume (lots) | 535 |
| 20-day avg. volume (lots) | 1,601 |
| Volume ratio (volume ÷ 20-day avg.) | 0.33 |
Indicator
Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF (00897) Institutional flows, margin & short
| Date | Foreign | Inv. Trust | Dealer | Total |
|---|---|---|---|---|
| Date | Margin balance (lots) | Short balance (lots) | Short/margin ratio (%) |
|---|---|---|---|
Recommended brokerage accounts
如果想要開戶，目前新光證券的開戶好禮最多，新戶贈送證券期貨手續費折抵金 3000 元
也可以參考 Win投資證券開戶彙整 ，有更簡潔完善的資訊分享，包含特色、開戶禮等。
| 名稱 | 台股手續費 | 新戶禮 |
| 新光證券 (開戶點我) | 手續費 0 元 每月電子下單 100 萬以內 |
|
| 玉山證券 (開戶點我) | 2026 年 10 月起調降手續費率超低優惠。 詳 官網 | 新戶禮 $108 手續費回饋金 活動日期到 2027/9/30 |
| 國泰證券 (開戶點我) | 最低手續費 1 元 | 完成體驗登記+首筆成交回饋 300 元7-11數位商品卡券 2026/1/1~2026/12/31 |
| 口袋證券 (開戶點我) | 優惠價查詢 | 開立台股或台+美股送 $300 手續費折抵金 2026/10/1~12/31 |
(資料來源：各券商，最新資訊以各券商為主。資料整理：Win 投資)
My Watchlist
Sign in to build and track your own watchlist. Once you add symbols, you get a full closing report every day: health check, technical changes and a comparison against the TAIEX.